Sally has more than 18-year work experience in pharmaceutical drug development industry, including clinical operation, global quality assurance and leadership roles at AZ, Pfizer and CStone pharmaceutical.
She is now leading the R&D Quality Assurance team of APAC at AZ. Sally was selected as IFPMA (International Federation of Pharmaceutical Manufacturers amp; Associations) lead expert in 2019, since then, she has been working in global ICH Expert Working Group for ICH E6 revisions and related stakeholder engagement activities.
Sally used to be an ENT doctor before joining industry, she holds Master’s degree in clinical medicine, she graduated from Huaxi Medical Center of Sichuan University, under a partnership with Dalhousie University of Canada.
